首页> 外文期刊>Injury >Daily subcutaneous Teriparatide injection increased bone mineral density of newly formed bone after tibia distraction osteogenesis, a randomized study
【24h】

Daily subcutaneous Teriparatide injection increased bone mineral density of newly formed bone after tibia distraction osteogenesis, a randomized study

机译:每日皮下萜酰基氮酰胺注射液含有新成型骨的骨密度,胫骨牵引骨质发生后,随机研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Long bone defects are often treated by bone segment transport with the llizarov method requiring months spent with fixator mounted until bony consolidation of the newly formed bone. Shortening of consolidation would allow earlier fixator removal and earlier return to work. In pre-clinical studies parathyroid hormone, increased bone mineral density and mechanical properties of regenerate bone formed during distraction osteogenesis. Clinical studies showed that Teriparatide accelerated fracture healing in patients with osteoporotic fracture of the pelvis, hip, wrist and shoulder. We hypothesized that rhPTH(1-34) (Teriparatide) administered to patients who had undergone distraction osteogenesis, would increase mineralization of the regenerate formed during the consolidation phase.
机译:长骨缺陷通常通过骨段运输处理,其中Llizarov方法需要用固定器安装在内的数月,直到新形成的骨骼的骨巩固。 缩短整合将允许更早的固定器删除和早期回程工作。 在临床前研究甲状旁腺激素,增加骨矿物质密度和在分散骨内发生期间形成的再生骨的力学性能。 临床研究表明,骨盆,髋关节,手腕和肩部骨质疏松骨折患者的Teriparatide加速骨折愈合。 我们假设给予经历患病骨质发生的患者的rhPth(1-34)(Triparatide)将增加在固结阶段形成的再生的矿化。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号